Select country set
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

Zinc-Alpha-2-Glycoprotein Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, HRP-labelled antibody
  • Other names:ZA2G, ZAG, AZGP1, Zn-alpha-2-glycoprotein, Zn-alpha-2-GP, ZNGP1
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RD191093100R 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, HRP-labelled antibody


Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate

Sample Requirements

10 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

3–100 ng/ml

Limit of Detection

Analytical Limit of Detection is calculated from the real Zinc-Alpha-2-Glycoprotein values in wells and is 0.673 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 3.9%

Inter-assay (Run-to-Run)

n = 4; CV = 6.6%

Spiking Recovery


Dilution Linearity



  • bovine Non-detectable
  • cat Non-detectable
  • dog Non-detectable
  • goat Non-detectable
  • hamster Non-detectable
  • horse Non-detectable
  • mouse Non-detectable
  • pig Non-detectable
  • rabbit Non-detectable
  • rat Non-detectable
  • sheep Non-detectable
  • chicken Not tested
  • human Yes
  • monkey Yes (recommended dilution 1:400)


  • It is intended for research use only
  • The total assay time is less than 3 hours
  • The kit measures zinc-alpha-2-glycoprotein in serum and plasma (EDTA, citrate, heparin)
  • Assay format is 96 wells
  • Quality Controls are human serum based. No animal sera are used
  • Standard is recombinant protein based
  • Components of the kit are provided ready to use, concentrated or lyophilized

Research topic

Energy metabolism and body weight regulation, Oncology


Zinc-alpha-2-glycoprotein (ZAG, ZA2G, Azgp1, ZNGP1, Lipid-Mobilizing Factor, LMF) is a soluble 41 kDa glycoprotein belonging to the immunoglobuline protein family and consisting of a single polypeptide chain. Human ZAG shares 59% sequence identity with the murine homolog.

ZAG is closely related to antigens of the class1 major histocompatibility complex (MHC I) and shares 30-40 % sequence identity with the heavy chain of MHC I. Most MHC-I members heterodimerize with beta-2-microglobuline (b2m) and bind peptides derived from intracellular proteins to present them to cytotoxic T cells. In contrast, ZAG is a soluble protein rather than being anchored to plasma membranes that acts independently on b2m and binds the hydrophobic ligand which may relate to its function in lipid metabolism.

ZAG is widespread in body fluids and is also found in various human tissues such as adipose tissue, prostate, breast, skin, salivary gland, trachea, broncheus, lung, gastrointestinal tract, pancreas, liver and kidney. ZAG acts as a lipid mobilizing factor to induce lipolysis in adipocytes and plays an important role in lipid utilization and loss of adipose tissue, especially during cachexia, which occurs in patient suffering from cancer, AIDS and other chronic illnesses. The role of ZAG in cancer cachexia is also connected with its ability to directly influence expression of uncoupling proteins (UCPs) which are implicated in the regulation of energy balance. In human adipocytes, ZAG expression is regulated particularly through TNF-alpha and the PPAR gamma nuclear receptor. ZAG expression is also upregulated by glucocorticoides and attenuated by eicosapentaenoic acid (EPA) and beta-3-adrenoreceptor antagonists.

ZAG is overexpressed in certain human malignant tumors such as prostate, breast, lung or bladder cancer and can relate to tumor differentiation. Additionally, ZAG plays a role in obesity, diabetic kidney disorders, frontotemporal dementia and regulation of melanin production by melanocytes.

ZAG is proposed to have a therapeutic use in obesity and cachexia. It can be used as a marker for clinical analysis of diabetic nephropathy and as a marker for certain tumors..

Product References (32)


  • Aregger F, Pilop C, Uehlinger DE, Brunisholz R, Carrel TP, Frey FJ, Frey BM.Urinary proteomics before and after extracorporeal circulation in patients withand without acute kidney injury. J Thorac Cardiovasc Surg. 2010Mar;139(3):692-700. doi: 10.1016/j.jtcvs.2009.11.015. PubMed PMID: 20176211. See more on PubMed
  • Brettschneider J, Mogel H, Lehmensiek V, Ahlert T, Süssmuth S, Ludolph AC,Tumani H. Proteome analysis of cerebrospinal fluid in amyotrophic lateralsclerosis (ALS). Neurochem Res. 2008 Nov;33(11):2358-63. doi:10.1007/s11064-008-9742-5. Epub 2008 May 15. PubMed PMID: 18481174. See more on PubMed
  • Ceperuelo-Mallafré V, Escoté X, Viladés C, Peraire J, Domingo P, Solano E,Sirvent JJ, Pastor R, Tinahones F, Leal M, Richart C, Vendrell J, Vidal F; HIV-1 Lipodystrophy Study Group, Alba V, Aguilar A, Auguet T, Chacón MR, López-Dupla M,Megia A, Miranda M, Olona M, Saurí A, Vargas M, Velasco I, Veloso S, Fontanet A, Gutiérrez M, Mateo G, Muñoz J, Sambeat MA. Zinc alpha-2 glycoprotein isimplicated in dyslipidaemia in HIV-1-infected patients treated withantiretroviral drugs. HIV Med. 2012 May;13(5):297-303. doi:10.1111/j.1468-1293.2011.00976.x. Epub 2012 Jan 19. PubMed PMID: 22256965. See more on PubMed
  • Ceperuelo-Mallafré V, Näf S, Escoté X, Caubet E, Gomez JM, Miranda M, ChaconMR, Gonzalez-Clemente JM, Gallart L, Gutierrez C, Vendrell J. Circulating andadipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: itsrelationship with adipokine and lipolytic gene markers in subcutaneous andvisceral fat. J Clin Endocrinol Metab. 2009 Dec;94(12):5062-9. doi:10.1210/jc.2009-0764. Epub 2009 Oct 21. PubMed PMID: 19846741. See more on PubMed
  • Dichgans M, Petersen D. Angiographic complications in CADASIL. Lancet. 1997Mar 15;349(9054):776-7. PubMed PMID: 9074584. See more on PubMed
  • Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, Bing C.Identification of macrophage inhibitory cytokine-1 in adipose tissue and itssecretion as an adipokine by human adipocytes. Endocrinology. 2009Apr;150(4):1688-96. doi: 10.1210/en.2008-0952. Epub 2008 Dec 12. PubMed PMID:19074584. See more on PubMed
  • Escoté X, Aranda GB, Mora M, Casals G, Enseñat J, Vidal O, Esteban Y, HalperinI, Hanzu FA. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.Endocrinol Diabetes Nutr. 2017 Jan;64(1):26-33. doi:10.1016/j.endinu.2016.10.002. Epub 2017 Jan 18. English, Spanish. PubMed PMID:28440767. See more on PubMed
  • Fain JN, Tagele BM, Cheema P, Madan AK, Tichansky DS. Release of 12 adipokinesby adipose tissue, nonfat cells, and fat cells from obese women. Obesity (Silver Spring). 2010 May;18(5):890-6. doi: 10.1038/oby.2009.335. Epub 2009 Oct 15.PubMed PMID: 19834460. See more on PubMed
  • Felix K, Fakelman F, Hartmann D, Giese NA, Gaida MM, Schnölzer M, Flad T,Büchler MW, Werner J. Identification of serum proteins involved in pancreaticcancer cachexia. Life Sci. 2011 Jan 31;88(5-6):218-25. doi:10.1016/j.lfs.2010.11.011. Epub 2010 Nov 19. PubMed PMID: 21094171. See more on PubMed
  • Gao D, Trayhurn P, Bing C. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol. 2010 Aug30;325(1-2):135-42. doi: 10.1016/j.mce.2010.05.020. Epub 2010 Jun 8. PubMed PMID:20595026. See more on PubMed
  • Garrido-Sánchez L, García-Fuentes E, Fernández-García D, Escoté X, Alcaide J, Perez-Martinez P, Vendrell J, Tinahones FJ. Zinc-alpha 2-glycoprotein geneexpression in adipose tissue is related with insulin resistance and lipolyticgenes in morbidly obese patients. PLoS One. 2012;7(3):e33264. doi:10.1371/journal.pone.0033264. Epub 2012 Mar 19. PubMed PMID: 22442679; PubMedCentral PMCID: PMC3307730. See more on PubMed
  • Gong FY, Zhang SJ, Deng JY, Zhu HJ, Pan H, Li NS, Shi YF.Zinc-alpha2-glycoprotein is involved in regulation of body weight throughinhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond). 2009Sep;33(9):1023-30. doi: 10.1038/ijo.2009.141. Epub 2009 Jul 21. PubMed PMID:19621019. See more on PubMed
  • Jernås M, Olsson B, Sjöholm K, Sjögren A, Rudemo M, Nellgård B, Carlsson LM,Sjöström CD. Changes in adipose tissue gene expression and plasma levels ofadipokines and acute-phase proteins in patients with critical illness.Metabolism. 2009 Jan;58(1):102-8. doi: 10.1016/j.metabol.2008.08.012. PubMedPMID: 19059537. See more on PubMed
  • Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, Abdalla DS, Leite M Jr, Mafra D. Is zinc-α2-glycoprotein a cardiovascular protective factor for patientsundergoing hemodialysis? Clin Chim Acta. 2012 Mar 22;413(5-6):616-9. doi:10.1016/j.cca.2011.12.002. Epub 2011 Dec 11. PubMed PMID: 22178218. See more on PubMed
  • Lee YP, Chang CH, Liu HH, Chen CY, Chen CY, Hsu CC, Chang CI, Lin YT, Lee CS, Tsai JS. Plasma zinc alpha2-glycoprotein levels correlate positively with frailtyseverity in female elders. Medicine (Baltimore). 2016 Aug;95(35):e4753. doi:10.1097/MD.0000000000004753. PubMed PMID: 27583927; PubMed Central PMCID:PMC5008611. See more on PubMed
  • Liu M, Zhu H, Dai Y, Pan H, Li N, Wang L, Yang H, Yan K, Gong F.Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-InducedObese Mice. Front Physiol. 2018 Feb 7;9:62. doi: 10.3389/fphys.2018.00062.eCollection 2018. PubMed PMID: 29467670; PubMed Central PMCID: PMC5808341. See more on PubMed
  • Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J, Trayhurn P, BingC. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat massexpansion in obesity. Clin Endocrinol (Oxf). 2010 Mar;72(3):334-41. doi:10.1111/j.1365-2265.2009.03658.x. Epub 2009 Jun 22. PubMed PMID: 19549246. See more on PubMed
  • Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, Rydén M, Arner P, Trayhurn P,Fearon KC, Bing C. Enhanced ZAG production by subcutaneous adipose tissue islinked to weight loss in gastrointestinal cancer patients. Br J Cancer. 2011 Feb 1;104(3):441-7. doi: 10.1038/sj.bjc.6606083. Epub 2011 Jan 18. PubMed PMID:21245862; PubMed Central PMCID: PMC3049573. See more on PubMed
  • Olofsson LE, Olsson B, Lystig T, Jacobson P, Jernås M, Sjöholm K, Gummesson A,Sjöström L, Eriksson P, Hamsten A, Hale LP, Thelle DS, Carlsson B, Carlsson LM.Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels areassociated with serum lipids. Metabolism. 2010 Sep;59(9):1316-8. doi:10.1016/j.metabol.2009.12.006. Epub 2010 Jan 12. PubMed PMID: 20070991. See more on PubMed
  • Philipp A, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Blüher M, StumvollM, Fasshauer M. Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism. 2011 May;60(5):669-72. doi:10.1016/j.metabol.2010.06.019. Epub 2010 Aug 12. PubMed PMID: 20708203. See more on PubMed
  • Riaz S, Skinner V, Srai SK. Effect of high dose thiamine on the levels ofurinary protein biomarkers in diabetes mellitus type 2. J Pharm Biomed Anal. 2011Mar 25;54(4):817-25. doi: 10.1016/j.jpba.2010.11.008. Epub 2010 Nov 13. Erratumin: J Pharm Biomed Anal. 2011 Aug 25;56(1):139. PubMed PMID: 21130593. See more on PubMed
  • Roher AE, Maarouf CL, Sue LI, Hu Y, Wilson J, Beach TG. Proteomics-derivedcerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. Biomarkers.2009 Nov;14(7):493-501. doi: 10.3109/13547500903108423. PubMed PMID: 19863188;PubMed Central PMCID: PMC2824250. See more on PubMed
  • Simó R, Hernández C, Sáez-López C, Soldevila B, Puig-Domingo M, Selva DM.Thyroid hormone upregulates zinc-α2-glycoprotein production in the liver but not in adipose tissue. PLoS One. 2014 Jan 21;9(1):e85753. doi:10.1371/journal.pone.0085753. eCollection 2014. PubMed PMID: 24465683; PubMedCentral PMCID: PMC3897515. See more on PubMed
  • Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V,Avihingsanon Y. Urinary proteomics revealed prostaglandin H(2)D-isomerase, notZn-α2-glycoprotein, as a biomarker for active lupus nephritis. J Proteomics. 2012Jun 18;75(11):3240-7. doi: 10.1016/j.jprot.2012.03.034. Epub 2012 Mar 30. PubMed PMID: 22498882. See more on PubMed
  • Sörensen-Zender I, Beneke J, Schmidt BM, Menne J, Haller H, Schmitt R.Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease. BMCNephrol. 2013 Jul 12;14:145. doi: 10.1186/1471-2369-14-145. PubMed PMID:23849457; PubMed Central PMCID: PMC3717003. See more on PubMed
  • Stejskal D, Karpísek M, Reutová H, Stejskal P, Kotolová H, Kollár P.Determination of serum zinc-alpha-2-glycoprotein in patients with metabolicsyndrome by a new ELISA. Clin Biochem. 2008 Mar;41(4-5):313-6. Epub 2007 Nov 29. PubMed PMID: 18078816. See more on PubMed
  • Tedeschi S, Pilotti E, Parenti E, Vicini V, Coghi P, Montanari A, Regolisti G,Fiaccadori E, Cabassi A. Serum adipokine zinc α2-glycoprotein and lipolysis incachectic and noncachectic heart failure patients: relationship withneurohormonal and inflammatory biomarkers. Metabolism. 2012 Jan;61(1):37-42. doi:10.1016/j.metabol.2011.05.011. Epub 2011 Jun 21. PubMed PMID: 21696792. See more on PubMed
  • Vanni H, Kazeros A, Wang R, Harvey BG, Ferris B, De BP, Carolan BJ, Hübner RH,O'Connor TP, Crystal RG. Cigarette smoking induces overexpression of afat-depleting gene AZGP1 in the human. Chest. 2009 May;135(5):1197-1208. doi:10.1378/chest.08-1024. Epub 2009 Feb 2. PubMed PMID: 19188554; PubMed CentralPMCID: PMC2679098. See more on PubMed
  • Wargent ET, O'Dowd JF, Zaibi MS, Gao D, Bing C, Trayhurn P, Cawthorne MA, ArchJR, Stocker CJ. Contrasts between the effects of zinc-α2-glycoprotein, a putativeβ3/2-adrenoceptor agonist and the β3/2-adrenoceptor agonist BRL35135 in C57Bl/6(ob/ob) mice. J Endocrinol. 2013 Jan 18;216(2):157-68. doi: 10.1530/JOE-12-0402. Print 2013 Feb. PubMed PMID: 23151357. See more on PubMed
  • Xiao XH, Qi XY, Li JY, Wang YB, Wang YD, Liao ZZ, Yang J, Ran L, Wen GB, LiuJH. Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroidhormone in newly diagnosed hyperthyroidism. BMC Endocr Disord. 2019 Jan22;19(1):12. doi: 10.1186/s12902-019-0336-9. PubMed PMID: 30670019; PubMedCentral PMCID: PMC6343254. See more on PubMed
  • Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc-alpha2-glycoproteincorrelates with adiposity, triglycerides, and the key components of the metabolicsyndrome in Chinese subjects. J Clin Endocrinol Metab. 2009 Jul;94(7):2531-6.doi: 10.1210/jc.2009-0058. Epub 2009 Apr 7. PubMed PMID: 19351730. See more on PubMed
  • Zhu HJ, Wang XQ, Pan H, Gong FY, Zhang DX, Li NS, Wang LJ, Yang HB. SerumLevels of the Adipokine Zinc- α 2-glycoprotein Are Decreased in Patients withHypertension. ISRN Endocrinol. 2014 Feb 9;2014:374090. doi: 10.1155/2014/374090. eCollection 2014. PubMed PMID: 24665369; PubMed Central PMCID: PMC3934454. See more on PubMed
Summary References (19)

References to Zinc-Alpha-2-Glycoprotein

  • Araki T, Gejyo F, Takagaki K, Haupt H, Schwick HG, Burgi W, Marti T, Schaller J, Rickli E, Brossmer R, et al. Complete amino acid sequence of human plasma Zn-alpha 2-glycoprotein and its homology to histocompatibility antigens. Proc Natl Acad Sci U S A. 1988 Feb;85 (3):679-83
  • Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett. 2005 Jan 3;579 (1):41-7
  • Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature. 2000 Jan 6;403 (6765):46-53
  • Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A. 2004 Feb 24;101 (8):2500-5
  • Brysk MM, Lei G, Adler-Storthz K, Chen Z, Brysk H, Tyring SK, Arany I. Zinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumors. Cancer Lett. 1999 Mar 22;137 (1):117-20
  • Brysk MM, Lei G, Selvanayagam P, Brysk H, Tyring SK, Arany I. Modulation by interferon-gamma of zinc-alpha 2-glycoprotein gene expression in human epithelial cell lines. Anticancer Res. 1997 Sep-Oct;17 (5A):3387-91
  • BURGI W, SCHMID K. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem. 1961 Apr;236:1066-74
  • Burmeister WP, Gastinel LN, Simister NE, Blum ML, Bjorkman PJ. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature. 1994 Nov 24;372 (6504):336-43
  • Diez-Itza I, Sanchez LM, Allende MT, Vizoso F, Ruibal A, Lopez-Otin C. Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur J Cancer. 1993;29A (9):1256-60
  • Freije JP, Fueyo A, Uria JA, Velasco G, Sanchez LM, Lopez-Boado YS, Lopez-Otin C. Human Zn-alpha 2-glycoprotein: complete genomic sequence, identification of a related pseudogene and relationship to class I major histocompatibility complex genes. Genomics. 1993 Dec;18 (3):575-87
  • Gohda T, Makita Y, Shike T, Tanimoto M, Funabiki K, Horikoshi S, Tomino Y. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?. Diabetes. 2003 Aug;52 (8):2175-81
  • Hale LP. Zinc alpha-2-glycoprotein regulates melanin production by normal and malignant melanocytes. J Invest Dermatol. 2002 Aug;119 (2):464-70
  • Hale LP, Price DT, Sanchez LM, Demark-Wahnefried W, Madden JF. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res. 2001 Apr;7 (4):846-53
  • Hansson SF, Puchades M, Blennow K, Sjogren M, Davidsson P. Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Sci. 2004 Nov 18;2 (1):7
  • Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998 Jun 1;58 (11):2359-65
  • Im JS, Yu KO, Illarionov PA, LeClair KP, Storey JR, Kennedy MW, Besra GS, Porcelli SA. Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes. J Biol Chem. 2004 Jan 2;279 (1):299-310
  • Jain S, Rajput A, Kumar Y, Uppuluri N, Arvind AS, Tatu U. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India. 2005 Jun;53:513-20
  • Kamoshida S, Watanabe K, Suzuki M, Mizutani Y, Sakamoto K, Sugimoto Y, Oka T, Fukushima M, Tsutsumi Y. Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysis. Biomed Res. 2006 Dec;27 (6):275-81
  • Lopez-Boa
Related Products Docs